Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
The Journal of the Royal College of Physicians of Edinburgh
|
March 24, 2012
RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'
D J Stott, R I Dewar, C J Garratt, et al.
European Journal of Clinical Pharmacology
|
December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies
S Trompet, I Postmus, P E Slagboom, et al.
Brain : a Journal of Neurology
|
February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study
S Trompet, A J M de Craen, P Slagboom, et al.
Experimental Gerontology
|
May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study
S Trompet, A J M de Craen, P Slagboom, et al.
Diabetologia
|
November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly
N Sattar, H M Murray, P Welsh, et al.
The American Journal of Cardiology
|
November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk
J Shepherd, G J Blauw, M B Murphy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk
P J Houx, J Shepherd, G-J Blauw, et al.
Annals of the New York Academy of Sciences
|
April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study
S Trompet, D Pons, A J M DE Craen, et al.
BMC Endocrine Disorders
|
September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over
R S Du Puy, I Postmus, D J Stott, et al.
The Pharmacogenomics Journal
|
December 7, 2019
Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry
Lisa de las Fuentes, Y J Sung, C M Sitlani, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
The Journal of the Royal College of Physicians of Edinburgh
|
March 24, 2012
RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'
D J Stott, R I Dewar, C J Garratt, et al.
European Journal of Clinical Pharmacology
|
December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies
S Trompet, I Postmus, P E Slagboom, et al.
Brain : a Journal of Neurology
|
February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study
S Trompet, A J M de Craen, P Slagboom, et al.
Experimental Gerontology
|
May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study
S Trompet, A J M de Craen, P Slagboom, et al.
Diabetologia
|
November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly
N Sattar, H M Murray, P Welsh, et al.
The American Journal of Cardiology
|
November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk
J Shepherd, G J Blauw, M B Murphy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk
P J Houx, J Shepherd, G-J Blauw, et al.
Annals of the New York Academy of Sciences
|
April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study
S Trompet, D Pons, A J M DE Craen, et al.
BMC Endocrine Disorders
|
September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over
R S Du Puy, I Postmus, D J Stott, et al.
The Pharmacogenomics Journal
|
December 7, 2019
Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry
Lisa de las Fuentes, Y J Sung, C M Sitlani, et al.
Page
of 8